BioCentury
ARTICLE | Company News

Nodality, UCB partner in immunology deal

February 11, 2012 12:45 AM UTC

Nodality Inc. (South San Francisco, Calif.) and UCB Group (Euronext:UCB) partnered to develop UCB compounds using Nodality's Single Cell Network Profiling (SCNP) technology. The technology analyzes intracellular pathway proteins and their activation states after stimulation by biologically relevant modulators. ...